Exploring IKKβ as an antiangiogenic therapeutic target in KRAS-induced lung cancer (2018)
- Authors:
- USP affiliated authors: GIORDANO, RICARDO JOSÉ - IQ ; BASSÈRES, DANIELA SANCHEZ - IQ
- Unidade: IQ
- Subjects: NEOPLASIAS PULMONARES; MUTAÇÃO
- Language: Inglês
- Imprenta:
- Publisher place: Philadelphia
- Date published: 2018
- Source:
- Título do periódico: Translational Cancer Medicine
- ISSN: 1078-0432
- Volume/Número/Paginação/Ano: v. 24, n. 1, suppl., res. B09, 2018
- Conference titles: AACR International Conference on Translational Cancer Medicine
-
ABNT
CARNEIRO LOBO, Tatiana Correa et al. Exploring IKKβ as an antiangiogenic therapeutic target in KRAS-induced lung cancer. Translational Cancer Medicine. Philadelphia: Instituto de Química, Universidade de São Paulo. Disponível em: http://clincancerres.aacrjournals.org/content/24/1_Supplement/B09. Acesso em: 19 abr. 2024. , 2018 -
APA
Carneiro Lobo, T. C., Santos, E. O. dos, Scalabrini, L. C., Cardeal, L. B. da S., Baldwin, A. S., Giordano, R. J., & Bassères, D. S. (2018). Exploring IKKβ as an antiangiogenic therapeutic target in KRAS-induced lung cancer. Translational Cancer Medicine. Philadelphia: Instituto de Química, Universidade de São Paulo. Recuperado de http://clincancerres.aacrjournals.org/content/24/1_Supplement/B09 -
NLM
Carneiro Lobo TC, Santos EO dos, Scalabrini LC, Cardeal LB da S, Baldwin AS, Giordano RJ, Bassères DS. Exploring IKKβ as an antiangiogenic therapeutic target in KRAS-induced lung cancer [Internet]. Translational Cancer Medicine. 2018 ; 24( 1):[citado 2024 abr. 19 ] Available from: http://clincancerres.aacrjournals.org/content/24/1_Supplement/B09 -
Vancouver
Carneiro Lobo TC, Santos EO dos, Scalabrini LC, Cardeal LB da S, Baldwin AS, Giordano RJ, Bassères DS. Exploring IKKβ as an antiangiogenic therapeutic target in KRAS-induced lung cancer [Internet]. Translational Cancer Medicine. 2018 ; 24( 1):[citado 2024 abr. 19 ] Available from: http://clincancerres.aacrjournals.org/content/24/1_Supplement/B09 - IKKβ targeting reduces KRAS-induced lung cancer angiogenesis in vitro and in vivo: a potential anti-angiogenic therapeutic target
- IKKβ is a potential anti-angiogenic therapeutic target in KRAS-induced lung cancer
- Aurora kinases: potential therapeutic targets in K-Ras-induced lung cancer
- Targeted BMI1 inhibition impairs tumor growth in lung adenocarcinomas with low CEBP alpha expression
- Exploring IKKβ kinase as a therapeutic target for KRAS-driven lung tumor initiating cells
- Exploring IKKβ as an anti-metastatic therapeutic target in KRAS-induced lung cancer
- Targeting Aurora A kinase activity in lung cancer initiating cells driven by oncogenic KRAS
- IKKβ inhibition suppresses sphere formation and self renewal of lung cancer initiating cells
- Aurora kinase targeting in lung cancer reduces KRAS-induced transformation
- IKKβ kinase promotes stemness, migration, and invasion in KRAS-driven lung adenocarcinoma cells
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
